## USER 🧑‍💻

<session_context>
This is the Gemini CLI. We are setting up the context for our chat.
Today's date is Thursday, April 23, 2026 (formatted according to the user's locale).
My operating system is: linux
The project's temporary directory is: /home/ericbell/.gemini/tmp/amethystb-0002-5
- **Workspace Directories:**
  - /home/ericbell/workspaces/dataannotation/AmethystB-0002.5
- **Directory Structure:**

Showing up to 200 items (files + folders). Folders or files indicated with ... contain more items not shown, were ignored, or the display limit (200 items) was reached.

/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/
├───260212 Encounter notes.md
├───260422 Office visit Healthcare statement redacted.pdf
├───grab-files.sh
└───.git/...


</session_context>

---

## USER 🧑‍💻

Here is the user's editor context as a JSON object. This is for your information only.
```json
{
  "activeFile": {
    "path": "/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/grab-files.sh",
    "cursor": {
      "line": 4,
      "character": 1
    }
  }
}
```

---

## USER 🧑‍💻

Act as a Certified Professional Medical Auditor (CPMA). Perform a technical compliance audit of the charges billed in "260422 Office visit Healthcare statement redacted.pdf" against the clinical encounter documentation provided in "260212 Encounter notes.md".

Using the 2021-2025 CMS Evaluation and Management (E/M) Documentation Guidelines, independently score the Medical Decision Making (MDM) level for this encounter and evaluate the appropriateness of the billed CPT 99214 and HCPCS G2211 codes. 

Please provide your deliverable as a formal Audit Findings Report containing the following sections:
1. MDM Element Analysis: An independent, element-by-element breakdown of your MDM scoring (Number and Complexity of Problems Addressed, Amount and/or Complexity of Data to be Reviewed and Analyzed, and Risk of Complications and/or Morbidity or Mortality of Patient Management).
2. Overall MDM Determination: The final supported E/M level based on your analysis of the three elements.
3. CPT 99214 Compliance Ruling: A definitive conclusion on whether the documentation supports the billed Level 4 visit, including the appropriate E/M code recommendation if the billed charge is unsupported.
4. HCPCS G2211 Evaluation: A strict technical assessment of whether the documentation satisfies Medicare's specific requirements for reporting this complex visit add-on code.

Your report must base all conclusions strictly on the provided documentation as evaluated under the applicable CMS guidelines.

---

## MODEL ✨

**Tool Command**:
```json
{
  "name": "activate_skill",
  "args": {
    "name": "medical-billing-em-audit-cms-medicare"
  },
  "id": "4lkj6pi7"
}
```**Tool Command**:
```json
{
  "name": "read_file",
  "args": {
    "file_path": "/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/260212 Encounter notes.md"
  },
  "id": "49d99570"
}
```**Tool Command**:
```json
{
  "name": "read_file",
  "args": {
    "file_path": "/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/260422 Office visit Healthcare statement redacted.pdf"
  },
  "id": "0avd59u9"
}
```

---

## USER 🧑‍💻

**Tool Response**:
```json
{
  "id": "4lkj6pi7",
  "name": "activate_skill",
  "response": {
    "output": "<activated_skill name=\"medical-billing-em-audit-cms-medicare\">\n  <instructions>\n    # CMS / Medicare Outpatient E/M Audit Skill (2021–2025)\n\n## Purpose\nUse this skill to audit office or outpatient E/M charges using:\n- the encounter note, and\n- the billing statement.\n\nThe goal is simple:\n**Does the documentation support what was billed?**\n\nWrite an **audit findings report**, not a summary or opinion.\n\n\n\n## Core principles\n\n- The **note controls the code**, not the bill.\n- Do not assume the billed level is correct.\n- Do not stretch documentation to justify a higher level.\n- If documentation is thin or mixed, score conservatively.\n- Separate **what is mentioned** from **what is actually managed**.\n\n\n\n## Workflow\n\n### 1) Identify what was billed\nFrom the billing statement:\n- confirm date of service,\n- identify billed E/M code (or description),\n- identify any add-on codes (e.g., G2211).\n\nMap descriptions carefully if codes are not shown.\n\n\n\n### 2) Use the correct framework\n- Use **2021–2025 CMS outpatient E/M rules**\n- Use **MDM**, not time (unless the note explicitly supports time)\n- For established patients, apply the correct E/M code family\n\n\n\n### 3) Build the real problem list\n\nList every issue, then sort into:\n\n- **Actively addressed (counts toward MDM)**\n- Mentioned but not meaningfully managed\n- History/background only\n- Resolved or inactive\n- Patient speculation without clinical action\n\nKey question:\n**What did the provider actually do about this problem today?**\n\n\n\n## 4) Score MDM elements separately\n\n### A. Number and Complexity of Problems Addressed\n\nThis is where most errors happen. Be strict.\n\n#### What counts\nOnly include problems that are **actively evaluated or managed**.\n\nExamples:\n- Stable chronic illness **with evaluation or management**\n- Acute illness addressed at the visit\n- Chronic illness with exacerbation **and active management**\n- New problem with real diagnostic or management work\n\n\n\n#### What does NOT meaningfully count\n\nDo NOT use these to raise the level:\n\n- Stable conditions with “continue current management”\n- Monitoring-only problems\n- Resolved conditions\n- Symptoms with no management decision\n- Conditions listed in history or med list only\n- Patient concerns without clinical action\n\n\n\n#### Moderate vs Low — the key rule\n\n**Do NOT reach Moderate by stacking weak problems.**\n\nModerate Problems requires:\n- At least **one problem that clearly drives management at a higher level**, OR\n- Multiple problems that each require meaningful work\n\n\n\n#### Practical guardrails\n\n- If most problems are “stable,” “monitor,” or “no change” → **LOW**\n- A single “exacerbation” without treatment change is often still **LOW**\n- A medication follow-up visit is often **LOW** unless complexity is clear\n\nAsk:\n**Did anything meaningful change today because of this problem?**\n\n\n\n#### Critical rule\n\n**Multiple low-level problems do NOT combine into Moderate.**\n\nIf no single problem clearly supports Moderate complexity:\n→ Score **LOW**\n\n\n\n### B. Amount and/or Complexity of Data\n\nCount only what is clearly documented.\n\n#### Counts:\n- External note review\n- Test ordering or review\n- Independent historian\n- Independent interpretation\n- Discussion with another clinician\n\n#### Does NOT count:\n- General familiarity with patient\n- Mention of prior care\n- Referral plans or self-referral\n- Medication list or vitals alone\n\nIf not clearly documented:\n→ **Minimal or None**\n\n\n\n### C. Risk of Complications and/or Morbidity or Mortality\n\nFocus on **management decisions made today**.\n\n#### Moderate risk commonly includes:\n- **Prescription drug management**\n\nThis includes:\n- starting,\n- renewing,\n- adjusting,\n- or actively managing a prescription\n\n\n\n#### Important distinction\n\n**Prescription management affects RISK — not automatically PROBLEMS**\n\nDo NOT upgrade the Problems element just because a prescription was written.\n\n\n\n#### Do not over-read risk\n\n- OTC use alone → not moderate\n- Historical risk → does not count\n- Medication listed without management → weak\n\n\n\n## 5) Apply the 2-out-of-3 rule\n\nOverall MDM level = highest level met by **at least 2 of 3 elements**.\n\n- One strong element does NOT control the visit\n- Do not override the rule\n\n\n\n## 6) Evaluate add-on codes separately\n\nDo not assume a valid E/M code supports an add-on code.\n\n\n\n### G2211 (Medicare complexity add-on)\n\nRequires documentation showing:\n\n- Ongoing, longitudinal care relationship **AND**\n- Visit complexity tied to being the focal point for care\n\n\n\n#### Not sufficient by itself:\n\n- Provider specialty (e.g., PCP)\n- Multiple diagnoses listed\n- Routine follow-up visit\n- Prescription renewal (including controlled substances)\n- Detailed note without clear complexity\n\n\n\n#### Practical rule\n\nIf the note does not clearly show:\n- longitudinal responsibility, OR\n- care of a serious/complex condition\n\n→ **G2211 is unsupported**\n\n\n\n## 7) Write the audit report\n\nUse this structure:\n\n### 1. Medical Decision Making (MDM) Analysis\n- Problems\n- Data\n- Risk\n\nFor each:\n- state supported level\n- explain why higher level is NOT supported if relevant\n\n\n\n### 2. E/M Level Determination\n- Apply 2-out-of-3 rule\n- State whether billed code is supported\n- If not, give correct level\n\n\n\n### 3. Add-on Code Compliance\n- Evaluate separately\n- State clearly: supported or unsupported\n- Explain why\n\n\n\n### 4. Final Conclusion\n\n- Billed E/M code\n- Supported E/M code\n- Add-on code status\n- One-line basis\n\n\n\n## Common mistakes to avoid\n\n### 1) Counting everything as a problem\nNarrative ≠ management\n\n\n\n### 2) Stacking weak problems\nStable + monitor + history ≠ Moderate\n\n\n\n### 3) Letting one element drive the visit\nRisk alone does not determine level\n\n\n\n### 4) Treating prescription as automatic Moderate overall\nIt supports **Risk only**\n\n\n\n### 5) Treating referrals as data\nPlanning a referral ≠ reviewing data\n\n\n\n### 6) Assuming add-on codes are automatic\nThey require separate support\n\n\n\n### 7) Missing the “active vs passive” distinction\nOnly active management counts\n\n\n\n## Final check before answering\n\n- Did you identify the billed code?\n- Did you confirm the date of service matches?\n- Did you separate active vs passive problems?\n- Did you score Problems, Data, Risk separately?\n- Did you apply 2-of-3 rule correctly?\n- Did you avoid using time unless supported?\n- Did you review add-on code separately?\n- Did you explain why higher level is NOT supported?\n\n\n\n## Tone\n\n- Write like a medical auditor\n- Be direct and practical\n- Do not overstate\n- Stay grounded in the note\n\n\n\n## Default closing\n\n- **Billed E/M code:** [code]\n- **Supported E/M code:** [code]\n- **Add-on code:** [supported / unsupported]\n- **Basis:** [short explanation]\n  </instructions>\n\n  <available_resources>\n    Showing up to 200 items (files + folders).\n\n/home/ericbell/.gemini/skills/medical-billing-em-audit-cms-medicare/\n└───SKILL.md\n  </available_resources>\n</activated_skill>"
  }
}
```**Tool Response**:
```json
{
  "id": "49d99570",
  "name": "read_file",
  "response": {
    "output": "I understand. You need a faithful, line-by-line reproduction of the original document provided, maintaining the structure and specific phrasing while strictly masking all **Personally Identifiable Information (PII)** and **Protected Health Information (PHI)**.\n\nBelow is the redacted version of the document, including the header information and full narrative notes.\n\n---\n\n### [REDACTED] Chart - Past Visit Details\n**Name:** [REDACTED] | **DOB:** [REDACTED] | **MRN:** [REDACTED] | **PCP:** [REDACTED], MD | [cite_start]**Legal Name:** [REDACTED] [cite: 3]\n[cite_start]**Office Visit - Feb 12, 2026** [cite: 4]\n[cite_start]**with [REDACTED], MD at [REDACTED] Physicians Primary Care, [REDACTED]** [cite: 5]\n\n---\n\n#### [cite_start]Notes from Care Team [cite: 6]\n[cite_start]**Daily Progress Notes by [REDACTED], MD at 2/12/2026 11:00 AM** [cite: 7]\n[cite_start]**Patient ID:** [REDACTED] is a 66 y.o. male. [cite: 8]\n\n[cite_start]**HPI** [cite: 9]\n1. [cite_start]**Controlled substance prescription renewal** [cite: 10]\n[cite_start]This visit is a check-in regarding a new prescription for a controlled substance. [cite: 11] [cite_start]He reports taking it for anxiety, particularly at nighttime when his mind races and he reflects on his past. [cite: 12] [cite_start]He describes these experiences as \"the ghosts of your past\" coming to visit. [cite: 13] [cite_start]He finds the anxiety awful at times. [cite: 13] [cite_start]He has taken the medication twice in the past week, which is unusual for him as he can go long periods without it. [cite: 14] [cite_start]He reports appropriate use of the medication, taking it as needed to \"quiet my mind down.\" [cite: 15] [cite_start]The prescription has been sent to the pharmacy for use at bedtime as needed. [cite: 16]\n\n2. [cite_start]**Shoulder pain** [cite: 17]\n[cite_start]Reports a history of a shoulder problem for which he has received physical therapy on two separate occasions. [cite: 18] [cite_start]He is now completely pain-free for the first time in years. [cite: 19] [cite_start]This resolution of pain started approximately six months ago. [cite: 19] [cite_start]He now has a full range of motion without any pain. [cite: 20] [cite_start]He can reach back to his side table while in bed, an action that previously always caused pain but now does not hurt at all. [cite: 21]\n\n3. [cite_start]**Morton's neuroma and new numbness** [cite: 22]\n[cite_start]He was previously diagnosed with a Morton's neuroma by a podiatrist. [cite: 23] [cite_start]He continues to wear insoles for this condition, and this has not changed. [cite: 24] [cite_start]In the last couple of weeks, he has developed a new area of numbness on his foot. [cite: 25] [cite_start]He describes it as not a profound numbness, as he can still feel touch, but the sensation is different. [cite: 26] [cite_start]He speculates it may be a pinched nerve. [cite: 27] [cite_start]He does not feel it is a threatening issue. [cite: 27]\n\n4. [cite_start]**GERD** [cite: 28]\n[cite_start]Reports ongoing issues with GERD. [cite: 29] [cite_start]He feels that this condition is under control. [cite: 29]\n\n5. [cite_start]**General stiffness and aging** [cite: 30]\n[cite_start]He is 67 years old. [cite: 34] [cite_start]He notes increased stiffness and difficulty with mobility, such as getting up from the floor or a couch after sitting for a while. [cite: 34] [cite_start]He reports making noises upon exertion, similar to his father. [cite: 35]\n\n6. [cite_start]**Weight management** [cite: 36]\n[cite_start]He is actively working on weight management. [cite: 37] [cite_start]He reports his current weight is 216-217 lbs, which is an improvement from previous years. [cite: 37] [cite_start]His goal is to reach approximately 200 lbs while maintaining muscle mass. [cite: 38]\n\n7. [cite_start]**Exercise** [cite: 39]\n[cite_start]He reports doing \"virtually nothing\" for routine exercise, especially due to the weather. [cite: 40] [cite_start]However, he engages in physically demanding activities around the house and yard, such as snow blowing a large area (deck, front walkway, 75-foot driveway, and a $25 \\times 25$ paddock). [cite: 41] [cite_start]He is mindful to engage his core muscles to stabilize his body and prevent injury. [cite: 42] [cite_start]He describes his pace during these activities and errands like grocery shopping as fast and purposeful. [cite: 43] [cite_start]He experiences some muscle soreness in his back afterward, which is expected given the sporadic nature of the intense activity. [cite: 44] [cite_start]This soreness resolves with a single dose of ibuprofen. [cite: 45]\n\n8. [cite_start]**Anxiety and sleep** [cite: 46]\n[cite_start]He experiences anxiety, particularly at night, which can interfere with his sleep. [cite: 47] [cite_start]Last night, he took ibuprofen for body aches and had a great night's sleep. [cite: 48] [cite_start]He notes that the night before, he only slept for four hours. [cite: 49] [cite_start]He is generally reluctant to take medication unless his body hurts. [cite: 50] [cite_start]He experienced a brief moment of word-finding difficulty when trying to recall the name \"ibuprofen,\" which caused him some concern about age-related cognitive changes, but he was able to recall the name on his own. [cite: 51]\n\n9. [cite_start]**Lower back pain** [cite: 52]\n[cite_start]He has a history of significant back issues dating back 20-30 years. [cite: 53] [cite_start]He believes the nerves have \"deaden[ed] out\" over time, as a psychiatrist had previously suggested might happen, leading to a reduction in pain signals to the brain. [cite: 54] [cite_start]In the past few weeks, he has experienced a recurrence of some of the earliest onset symptoms. [cite: 55] [cite_start]While not frequent, it has happened a few times. [cite: 56] [cite_start]This has prompted him to consider reconnecting with the spine specialists he saw previously in [REDACTED], who had successfully helped him manage his condition and steered him away from surgery. [cite: 56] [cite_start]He recalls the admonition at that time was that discectomies had a 30% success rate and that scar tissue could worsen the outcome. [cite: 57] [cite_start]He feels it is a good idea to check in with them again. [cite: 58] [cite_start]He recalls his previous physician was Dr. [REDACTED], who was enormously helpful. [cite: 59] [cite_start]He described prior episodes of severe back pain that constricted his diaphragm and caused labored breathing, which was a frightening experience. [cite: 60]\n\n---\n\n[cite_start]**Past Medical History:** [cite: 63]\n* [cite_start]Hypertension [cite: 63]\n* [cite_start]Sleep apnea [cite: 63]\n\n[cite_start]**Social History** [cite: 64]\n* [cite_start]Reports that he has quit smoking. [cite: 66]\n* [cite_start]Reports that he does not drink alcohol and does not use drugs. [cite: 67]\n\n[cite_start]**Family History** [cite: 68]\n* Asthma in mother; Bleeding disorder in mother; Blood disorder in mother; [cite_start]Cancer in mother. [cite: 69, 70]\n* [cite_start]Dementia in paternal grandmother. [cite: 70]\n* [cite_start]Hypertension in father, mother, and other family member. [cite: 70, 71]\n\n[cite_start]**Surgical History** [cite: 72]\n* [cite_start]Cardiac electrophysiology procedure ([REDACTED], 9/12/2022). [cite: 73]\n\n[cite_start]**Medication List** [cite: 76]\n* [cite_start]acyclovir 400 MG tablet (ZOVIRAX) [cite: 80, 81]\n* [cite_start]coenzyme Q10 50 mg capsule [cite: 86]\n* [cite_start]lansoprazole 30 MG capsule (PREVACID) [cite: 87, 88]\n* [cite_start]metoprolol ER 25 MG 24 hr tablet (TOPROL-XL) [cite: 90, 91]\n* [cite_start]Moringa oleifera 500 mg Cap [cite: 93]\n\n[cite_start]**Vital Signs (2/12/2026 11:11 AM)** [cite: 106]\n* [cite_start]**Heart Rate:** 63 [cite: 113]\n* **Weight:** 223! (LB) [cite_start][cite: 114]\n* [cite_start]**BMI:** 32.1 [cite: 101]\n* [cite_start]**SpO2:** 98% [cite: 121]\n* [cite_start]**Blood Pressure:** 120/84 [cite: 121, 122]\n\n---\n\n[cite_start]**Assessment & Plan:** [cite: 128]\n1. [cite_start]**Anxiety** [cite: 129]\n    * [cite_start]Assessment: Likely diagnosis for Issue 1: Anxiety. [cite: 130]\n    * [cite_start]Treatment: New prescription for a controlled substance sent to pharmacy. [cite: 134] [cite_start]To be taken at bedtime as needed for anxiety and to aid sleep. [cite: 135]\n2. [cite_start]**Chronic Shoulder Pain** [cite: 136]\n    * [cite_start]Assessment: Resolved chronic shoulder pain. [cite: 137]\n    * Treatment: Continued observation. [cite_start]No active treatment needed. [cite: 137, 138]\n3. [cite_start]**Morton's Neuroma and New-onset Numbness** [cite: 139]\n    * [cite_start]Assessment: Morton's neuroma, new-onset peripheral neuropathy. [cite: 140]\n    * Treatment: Continue wearing insoles. [cite_start]Monitor new symptoms. [cite: 141]\n4. [cite_start]**GERD** [cite: 142]\n    * [cite_start]Assessment: GERD, stable. [cite: 143]\n    * [cite_start]Treatment: Continue current management. [cite: 144]\n5. [cite_start]**Lower Back Pain** [cite: 145]\n    * [cite_start]Assessment: Chronic lower back pain with recent exacerbation. [cite: 146]\n    * [cite_start]Referrals: Plans to self-refer back to previous spine specialist. [cite: 147] [cite_start]Discussed that with current Medicare plan, he can self-refer without issue. [cite: 148]\n\n[cite_start]**Diagnoses and all orders for this visit:** [cite: 149]\n* [cite_start]**Panic attacks** [cite: 150]\n* [cite_start]**ALPRAZolam (XANAX) 0.5 MG tablet;** Take 1 tablet at bedtime as needed for insomnia or anxiety. [cite: 151]"
  }
}
```**Tool Response**:
```json
{
  "id": "0avd59u9",
  "name": "read_file",
  "response": {
    "output": "Binary content provided (1 item(s))."
  }
}
```

---

## MODEL ✨

**Audit Findings Report**

### 1. Medical Decision Making (MDM) Element Analysis

**A. Number and Complexity of Problems Addressed: LOW**
The documentation reflects a routine check-in with a variety of patient concerns, none of which reflect moderate complexity or drive management at a higher level:
*   **Anxiety / Panic Attacks:** The patient presented for a check-in regarding a controlled substance renewal. He reported appropriate, as-needed use with no changes to the treatment plan. This qualifies as a stable chronic condition.
*   **Lower Back Pain:** The patient reported a recurrence of symptoms, but the clinical action was limited to discussing his ability to self-refer back to a previous specialist. No active treatment, medication adjustments, or diagnostics were initiated by the provider today. 
*   **Morton's Neuroma / New Numbness:** The condition is being monitored without active intervention ("continue wearing insoles"). 
*   **GERD:** Explicitly documented as stable with instructions to "continue current management."
*   **Shoulder Pain:** Documented as resolved requiring no active treatment.

*Analysis:* Multiple low-level problems do not stack to create moderate complexity. Because the actively managed problems consist of stable chronic illnesses and issues deferred to self-referral without any changes in management, this element is scored as **Low**.

**B. Amount and/or Complexity of Data to be Reviewed and Analyzed: MINIMAL OR NONE**
The documentation does not contain evidence of any tests being ordered or reviewed, external notes being analyzed, or an independent historian being utilized. A patient's intent to self-refer to a specialist does not count toward data. Therefore, this element is scored as **Minimal or None**.

**C. Risk of Complications and/or Morbidity or Mortality: MODERATE**
The provider authorized the renewal of a prescription for Alprazolam (Xanax) 0.5 mg, a controlled substance, to be taken as needed. Under CMS guidelines, active prescription drug management inherently supports **Moderate** risk. 

---

### 2. Overall MDM Determination
Under the CMS E/M guidelines, the overall MDM level is determined by the highest level met by at least two of the three elements (the "2-out-of-3 rule").
*   **Problems:** Low
*   **Data:** Minimal / None
*   **Risk:** Moderate

Because only the Risk element reaches Moderate, the highest level met by two elements is Low. (Note: Total encounter time was not explicitly documented in the note, meaning time cannot be used to override the MDM score). 

---

### 3. CPT 99214 Compliance Ruling
The billed CPT code 99214 requires a Moderate level of Medical Decision Making. Because the MDM scored as Low based strictly on the clinical documentation, the billed CPT 99214 is **unsupported**. 

The correct and supported evaluation and management code for this encounter is **CPT 99213** (Established Patient, Low MDM).

---

### 4. HCPCS G2211 Evaluation
HCPCS G2211 requires documentation showing that the visit's complexity is tied to being the ongoing focal point for all needed health care services, or for a single, serious, and complex condition. 

While the provider clearly acts as the patient's primary care physician, the note itself reflects a routine medication check-in for stable conditions alongside a detailed narrative of the patient's lifestyle and history. A standard prescription renewal (even for a controlled substance) and the listing of multiple low-complexity diagnoses do not satisfy Medicare's strict requirement for G2211 without clear, documented complexity driving the visit. Therefore, this add-on code is **unsupported**.

---

### Final Conclusion
*   **Billed E/M code:** 99214
*   **Supported E/M code:** 99213
*   **Add-on code:** Unsupported
*   **Basis:** The note reflects stable conditions and a prescription renewal. Only the Risk element reaches Moderate; Problems are Low and Data is Minimal, resulting in Low MDM overall. Time is not documented to override MDM. The documentation lacks the requisite complexity to support the G2211 add-on code.